The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines

<i>Background:</i> Approximately 10–20% of subjects vaccinated with HBsAg-based hepatitis B virus (HBV) vaccines are non-responders. BM32 is a recombinant grass pollen allergy vaccine containing the HBV-derived preS surface antigen as an immunological carrier protein. PreS includes the b...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Inna Tulaeva, Felix Lehmann, Nora Goldmann, Alexandra Dubovets, Daria Trifonova, Mikhail Tulaev, Carolin Cornelius, Milena Weber, Margarete Focke-Tejkl, Alexander Karaulov, Rainer Henning, David Niklas Springer, Ursula Wiedermann, Dieter Glebe, Rudolf Valenta
Format:	Article
Language:	English
Published:	MDPI AG 2024-09-01
Subjects:	HBV vaccines preS surface protein HBsAg non-responsiveness
Online Access:	https://www.mdpi.com/2076-393X/12/10/1123